Robert G Finizio Therapeutics Md, Inc. (TXMD) insider trading activity

TXMD Quotes by TradingView

Robert G Finizio is CEO of TherapeuticsMD, Inc.. Currently has a direct ownership of 18 Million shares of TXMD, which is worth approximately $28.2 Million. The most recent transaction as insider was on May 11, 2021, when has been sold 67,697 shares (Common Stock) at a price of $1.04 per share, resulting in proceeds of $70,405. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18M
0% 3M change
0% 12M change
Total Value Held $28.2 Million

Robert G Finizio Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 11 2021
SELL
Open market or private sale
$70,405 $1.04 p/Share
67,697 Reduced 0.37%
17,991,637 Common Stock
May 10 2021
BUY
Exercise of conversion of derivative security
-
158,334 Added 0.87%
18,059,334 Common Stock
Mar 05 2021
SELL
Bona fide gift
-
350,000 Reduced 1.89%
18,201,000 Common Stock
Mar 04 2021
SELL
Payment of exercise price or tax liability
$43,747 $1.46 p/Share
29,964 Reduced 0.16%
18,551,000 Common Stock
Mar 04 2021
BUY
Exercise of in-the-money or at-the-money derivatives securities
$42,960 $0.24 p/Share
179,000 Added 0.95%
18,580,964 Common Stock
Feb 28 2020
SELL
Bona fide gift
-
300,000 Reduced 1.65%
17,901,000 Common Stock

Also insider at

LSPR
Larkspur Health Acquisition Corp. Financial Services
Director
RGF

Robert G Finizio

CEO
Boca Raton, FL

Track Institutional and Insider Activities on TXMD

Follow TherapeuticsMD, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXMD shares.

Notify only if

Insider Trading

Get notified when an Therapeutics Md, Inc. insider buys or sells TXMD shares.

Notify only if

News

Receive news related to TherapeuticsMD, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TXMD